Back
MetLife Inc (MET)
InsuranceMET · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$90.10
−1.71%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$5.02
ROE
13.0%
Gross margin
23.8%
Debt/Equity
1.78x
Revenue growth
2.7%
MetLife Inc — company intelligence
Earnings surprises
Q1 2026$2.42 vs $2.29 est+5.5%
Q4 2025$2.58 vs $2.37 est+9.1%
Q3 2025$2.37 vs $2.34 est+1.2%
Q2 2025$2.02 vs $2.17 est-6.9%
Analyst consensus · 23 analysts
16 Buy7 Hold0 Sell
Updated Jul 8, 2026
Insider activity · 90 days
20 buys1 sellnet -1,063 shares
HUBBARD ROBERT GLENNBuy 1,016 · Jun 16, 2026
Mumenthaler Christian StephaneBuy 587 · Jun 16, 2026
Johnson Jeh C.Buy 587 · Jun 16, 2026
Recent SEC filings
8-K — Material event reportJun 29, 2026
8-K — Material event reportJun 22, 2026
4 — Insider transaction reportJun 18, 2026
Latest news
Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $103 — Benzinga · 5d ago
Will MetLife’s New Settlement Flexibility and Real Estate Moves Redefine Its Risk Profile (MET)? — Yahoo · 6d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About MetLife Inc
Weekly undervalued picks (like MET)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.